Inflammatory Diseases of the Middle Ear Workup

  • Author: Nasir Aziz, MD, MA; Chief Editor: Arlen D Meyers, MD, MBA   more...
 
Updated: Feb 1, 2010
 

Laboratory Studies

Culturing of the discharge after a spontaneous perforation in patients with acute suppurative otitis media is reliable in only the first few hours because external ear canal flora contaminates the otorrhea.

Next

Imaging Studies

  • Cholesteatoma is usually treated surgically. Bearing this in mind, radiologic evaluation serves to demonstrate any underlying anatomical variation and to assist in diagnosing both the extent and the nature of pathological change. The extent of mastoid pneumatization influences the surgical approach taken.
    • CT scanning is generally the imaging modality of choice in the assessment of cholesteatoma.
      • High-resolution CT scans can demonstrate bony erosion of the tegmen, the lateral semicircular, and the bony covering of the facial nerve. Ossicular erosion of the malleus and the incus is often visible on CT scans, although stapes erosion is frequently not demonstrated.
      • MRIs are inferior to CT scans in demonstrating bony abnormalities associated with cholesteatoma. However, MRIs help distinguish between the different pathological processes that cause soft tissue accumulation in the mastoid and the middle ear spaces.
      • MRIs are particularly useful in distinguishing among cholesteatoma, cholesterol granuloma, and inflammatory granulation tissue.
    • Radiologic documentation of ears with chronic cholesteatoma, which usually require surgery, reveals underlying anatomical variations and assists in diagnosis of the extent and the nature of the disease.
    • Plain radiographs may depict the height of the middle fossa dura and the site of the sigmoid sinus, but they usually reveal little information on the extent of disease.
      • Both CT scans and MRIs can reveal the disease and its extent.
      • CT scans reveal a nonenhancing mass eroding the bone, including the ossicles, with sharply defined smooth margins, isodense with CSF; likewise, MRI depicts a mass with a low-intensity T1-weighted signal and a high T2 signal. In practice, distinguishing between cholesteatoma and pure mucosal disease is often difficult on imaging.
    • A high-definition CT scan of the petrous temporal bone depicts the extent of the mastoid disease, although it may not assist in distinguishing cholesteatoma from mucosal disease.
  • High-resolution CT scanning has allowed better detection of acute otomastoiditis. The mastoid air cells appear opacified because of mucosal swelling and the presence of mucus or mucopurulent secretions. With effective therapy, the inflammatory process can be arrested, and the mastoid air cells resume a normal radiographic appearance.
  • A gadolinium-enhanced magnetic resonance scan is currently the imaging modality of choice to aid in the diagnosis of intracranial venous thrombosis and intracranial abscess.
    • With intracranial venous thrombosis, simple thrombus shows an intermediate signal; vascularized thrombus, granulation tissue, and slow-flowing blood show a high signal; and fast-flowing blood shows no signal.
    • Intracranial abscess shows a center of low attenuation with an outer rim of a high signal.
Previous
Next

Other Tests

  • Audiometry is not diagnostic, but it allows an examiner to assess the severity of the patient's condition.
    • Audiometry may also be used to monitor the progress of the patient's condition.
    • According to observations made in a prospective cohort study of 3-year-old children, dry ears have a mean hearing threshold of 17 dB, while ears with mild chronic secretory otitis media (SOM) and moderate chronic SOM have thresholds of 23 dB and 29 dB, respectively.
Previous
Next

Histologic Findings

The degree of inflammation in chronic suppurative otitis media (CSOM) without cholesteatoma is related to clinical activity, with the most intense changes seen in ears with continuous otorrhea. First, chronic inflammatory infiltrate (eg, lymphocytes, plasma cells, histiocytes) develops with increased capillary permeability of the lamina propria of the middle ear mucosa and resultant mucosal edema. The middle ear epithelium transforms as counts of goblet cells and ciliated cells increase, with the epithelium generally becoming more glandular and secretory.

Inflammatory granulation tissue develops during the early stages of healing after the destruction of the tissue. Sometimes, polyps covered with ciliated columnar epithelium form when the granulation tissue is florid. Later, the disease is characterized by decreased vascularity, fibrosis with sclerosis, and new bone formation in the mastoid air cells.

Ossicular changes are mainly due to osteoclastic bone resorption in granulation tissue or avascular necrosis. New bone formation may occur with fixation of the heads of the malleus and the incus in the attic. A foreign body granulomatous response to cholesterol crystals can result after hemorrhage into the middle ear, with crystals surrounded by foreign body giant cells and other chronic inflammatory cells. Tympanosclerosis is associated with CSOM with hyalinization of collagen and calcium deposition and may result from a specific autoimmune reaction.

Cholesteatomatous CSOM appears macroscopically as a crystallike structure with pale debris in the middle ear cleft. Light microscopy reveals a matrix of fully differentiated stratified squamous epithelium resting on connective tissue. The central core of cholesteatoma consists of anucleate keratin squames. Other inflammatory changes are similar to noncholesteatomatous CSOM, including aural polyps. Histologically, aural polyps that consist of granulation tissue with keratin as masses or flakes suggest that cholesteatoma is a likely diagnosis. Conversely, polyps without this feature but with lymphoid aggregates, a connective tissue core with glands, and a covering epithelium make cholesteatoma a much less likely diagnosis. Epidermal Langerhans cells are found in high numbers in cholesteatoma and are thought to be epidermal macrophages.

Previous
 
 
Contributor Information and Disclosures
Author

Nasir Aziz, MD, MA  Resident Physician, Riverside Regional Medical Center

Disclosure: Nothing to disclose.

Coauthor(s)

Diego A Preciado, MD, PhD, FAAP  Assistant Professor, Department of Otolaryngology, Division of Pediatric Otolaryngology, George Washington University School of Medicine, Children's National Medical Center

Diego A Preciado, MD, PhD, FAAP is a member of the following medical societies: Alpha Omega Alpha, American Academy of Otolaryngology-Head and Neck Surgery, American Academy of Pediatrics, American Society of Pediatric Otolaryngology, and Association for Research in Otolaryngology

Disclosure: Nothing to disclose.

Specialty Editor Board

John C Li, MD  Private Practice in Otology and Neurotology; Medical Director, Balance Center

John C Li, MD is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American College of Surgeons, American Medical Association, American Neurotology Society, American Tinnitus Association, Florida Medical Association, and North American Skull Base Society

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD  Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

Gerard J Gianoli, MD  Clinical Associate Professor, Department of Otolaryngology-Head and Neck Surgery, Tulane University School of Medicine; Vice President, The Ear and Balance Institute; Chief Executive Officer, Ponchartrain Surgery Center

Gerard J Gianoli, MD is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American College of Surgeons, American Neurotology Society, American Otological Society, Society of University Otolaryngologists-Head and Neck Surgeons, and Triological Society

Disclosure: Vesticon, Inc. None Board membership

Christopher L Slack, MD  Private Practice in Otolaryngology and Facial Plastic Surgery, Associated Coastal ENT; Medical Director, Treasure Coast Sleep Disorders

Christopher L Slack, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, and American Medical Association

Disclosure: Nothing to disclose.

Chief Editor

Arlen D Meyers, MD, MBA  Professor, Department of Otolaryngology-Head and Neck Surgery, University of Colorado School of Medicine

Arlen D Meyers, MD, MBA is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, and American Head and Neck Society

Disclosure: Covidien Corp Consulting fee Consulting; US Tobacco Corporation Unrestricted gift Unknown; Axis Three Corporation Ownership interest Consulting; Omni Biosciences Ownership interest Consulting; Sentegra Ownership interest Board membership; Syndicom Ownership interest Consulting; Oxlo Consulting; Medvoy Ownership interest Management position; Cerescan Imaging Honoraria Consulting; GYRUS ACMI Honoraria Consulting

Additional Contributors

The authors and editors of eMedicine gratefully acknowledge the contributions of previous author Sanjeev Silva, MBBS, MRCS, DLO, to the development and writing of this article.

References
  1. Iino Y, Nagamine H, Kakizaki K, et al. Effectiveness of instillation of triamcinolone acetonide into the middle ear for eosinophilic otitis media associated with bronchial asthma. Ann Allergy Asthma Immunol. Dec 2006;97(6):761-6. [Medline].

  2. Coughlin L. AHRQ data on antibiotic use in children with otitis media. American Family Physician. June 2005.

  3. Browning GC. Medical management of chronic mucosal otitis media. Clin Otolaryngol Allied Sci. Jun 1984;9(3):141-4. [Medline].

  4. Dubey SP, Larawin V, Molumi CP. Intracranial spread of chronic middle ear suppuration. Am J Otolaryngol. Mar 31 2009;[Medline].

  5. Balbani AP, Montovani JC. [Impact of otitis media on language acquisition in children]. J Pediatr (Rio J). Sep-Oct 2003;79(5):391-6. [Medline].

  6. Aberg B, Westin T, Tjellstrom A, Edstrom S. Clinical characteristics of cholesteatoma. Am J Otolaryngol. Sep-Oct 1991;12(5):254-8. [Medline].

  7. Balbani AP, Montovani JC. [Impact of otitis media on language acquisition in children]. J Pediatr (Rio J). Sep-Oct 2003;79(5):391-6. [Medline].

  8. Bluestone CD. Clinical course, complications and sequelae of acute otitis media. Pediatr Infect Dis J. May 2000;19(5 Suppl):S37-46. [Medline].

  9. Bluestone CD. Pathogenesis of otitis media: role of eustachian tube. Pediatr Infect Dis J. Apr 1996;15(4):281-91. [Medline].

  10. Casselbrant ML, Mandel EM, Rockette HE, Kurs-Lasky M, Fall PA, Bluestone CD, et al. The genetic component of middle ear disease in the first 5 years of life. Arch Otolaryngol Head Neck Surg. Mar 2004;130(3):273-8. [Medline].

  11. DeSouza CE, Menezes CO, DeSouza RA, Ogale SB, Morris M, Desai AP. Profile of congenital cholesteatomas of the petrous apex. J Postgrad Med. Apr 1989;35(2):93-7. [Medline].

  12. Dobben GD, Raofi B, Mafee MF, Kamel A, Mercurio S. Otogenic intracranial inflammations: role of magnetic resonance imaging. Top Magn Reson Imaging. Apr 2000;11(2):76-86. [Medline].

  13. Fireman P. Otitis media and eustachian tube dysfunction: connection to allergic rhinitis. J Allergy Clin Immunol. Feb 1997;99(2):S787-97. [Medline].

  14. Freid VM, Makuc DM, Rooks RN. Ambulatory health care visits by children: principal diagnosis and place of visit. Vital Health Stat 13. May 1998;(137):1-23. [Medline].

  15. Giles M, Asher I. Prevalence and natural history of otitis media with perforation in Maori school children. J Laryngol Otol. Apr 1991;105(4):257-60. [Medline].

  16. Harker LA, Koontz FP. The bacteriology of cholesteatoma. Cholesteatoma: First International Conference. 1977;287-92.

  17. Heikkinen T, Chonmaitree T. Importance of respiratory viruses in acute otitis media. Clin Microbiol Rev. Apr 2003;16(2):230-41. [Medline].

  18. Iino Y, Kakizaki K, Katano H, Saigusa H, Kanegasaki S. Eosinophil chemoattractants in the middle ear of patients with eosinophilic otitis media. Clin Exp Allergy. Oct 2005;35(10):1370-6. [Medline].

  19. Kangsanarak J, Fooanant S, Ruckphaopunt K, Navacharoen N, Teotrakul S. Extracranial and intracranial complications of suppurative otitis media. Report of 102 cases. J Laryngol Otol. Nov 1993;107(11):999-1004. [Medline].

  20. Katherine L. O'Brien and Mathuram Santosham Potential Impact of Conjugate Pneumococcal Vaccines on Pediatric Pneumococcal Diseases. 159. Am J Epidemiol; 2004:634-644.

  21. Mafee MF. MRI and CT in the evaluation of acquired and congenital cholesteatomas of the temporal bone. J Otolaryngol. Aug 1993;22(4):239-48. [Medline].

  22. Merifield DO, Parker NJ, Nicholson NC. Therapeutic management of chronic suppurative otitis media with otic drops. Otolaryngol Head Neck Surg. Jul 1993;109(1):77-82. [Medline].

  23. Miceli Sopo S, Zorzi G, Calvani M Jr. Should we screen every child with otitis media with effusion for allergic rhinitis?. Arch Dis Child. Mar 2004;89(3):287-8. [Medline].

  24. Michaels L. An epidermoid formation in the developing middle ear: possible source of cholesteatoma. J Otolaryngol. Jun 1986;15(3):169-74. [Medline].

  25. Patel JA, Nguyen DT, Revai K, Chonmaitree T. Role of respiratory syncytial virus in acute otitis media: implications for vaccine development. Vaccine. Feb 19 2007;25(9):1683-9. Epub 2006 Nov 9. [Medline].

  26. Pichichero ME, Pichichero CL. Persistent acute otitis media: I. Causative pathogens. Pediatr Infect Dis J. Mar 1995;14(3):178-83. [Medline].

  27. Poelmans J, Tack J. Extraoesophageal manifestations of gastro-oesophageal reflux. Gut. Oct 2005;54(10):1492-9. [Medline].

  28. Spector ND, Kelly SF. Medical home, obesity, acute otitis media, and otitis media with effusion. Curr Opin Pediatr. Dec 2004;16(6):706-22. [Medline].

  29. Stangerup SE, Tos M. Epidemiology of acute suppurative otitis media. Am J Otolaryngol. Jan-Feb 1986;7(1):47-54. [Medline].

Previous
Next
 
Middle ear anatomy.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.